| |
|
|
|
AC Immune S.A.  
|
|
6.99 0.12 (0.02%) |
09-17 16:00 |
|
Open: |
6.87 |
Pre close: |
6.87 |
Target:
|
11.84
|
|
High: |
7.02 |
Low: |
6.8 |
Resistance:
|
10.13
12.61
|
|
Volume: |
312,737 |
Market Cap: |
508M |
Support:
|
6.13
5.10
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.88
 |
MACD |
MACD(12,26):
|
-0.03  |
|
MA(20): |
7.03 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
7.07 |
Stochastic Oscillator |
%K(14,3):
|
4.11 |
|
MA(250): |
6.53 |
%D(3): |
3.65 |
|
Average Volume(K) |
3-Month: |
206737
|
52-Week |
High:
|
12.61 |
|
10-Days: |
54520 |
Low: |
4.42 |
|
RSI |
RSI(14):
|
49.23 |
Change(%): |
-21.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.070 |
Return on Equity (ttm) |
-33.8 |
Shares Out. (M) |
72.65 |
|
EPS Est. Current Year |
-0.620 |
Return on Assets (ttm) |
-19.1 |
Shares Float (M) |
21.89 |
|
EPS Est. Next Year |
-0.720 |
PEG Ratio |
0.00 |
% Held by Insiders |
60.85 |
|
EPS Est. Next Quarter |
-0.130 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
26.41 |
|
Forward EPS |
-0.837 |
Gross Profit (p.s.) |
-0.606 |
Shares Short (K) |
1170 |
|
Book Value (p.s.) |
2.870 |
EBITDA (p.s.) |
-0.998 |
P/E |
-6.53 |
|
Sales Per Share |
0.028 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.44 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-68.32 |
P/S |
245.32 |
|
Operating Margin |
-3592.01 |
Levered Free Cash Flow
(M) |
-42.91 |
P/CF |
-7.43 |
|
|
|
|
|
|
